Journal of Neuropsychiatry and Clinical Neurosciences 2011-01-01

Neuroleptic malignant syndrome induced by blonanserin.

Keiko Ohoyama, Hisashi Tanii, Eishi Motomura, Yoshiaki Konishi, Masanori Nakagawa, Takuya Matsumoto, Takashi Shiroyama, Motohiro Okada

Index: J. Neuropsychiatry Clin. Neurosci. 23(1) , E13, (2011)

Full Text: HTML

Abstract

Related Compounds

Related Articles:

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.

2013-01-01

[Clin. Neuropharmacol. 36(6) , 223-38, (2013)]

Blonanserin in the treatment of delirium.

2011-06-01

[Psychiatry Clin. Neurosci. 65(4) , 389-91, (2011)]

Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.

2010-12-01

[Psychogeriatrics 10(4) , 198-200, (2010)]

Development and validation of a stability-indicating gas chromatographic method for quality control of residual solvents in blonanserin: a novel atypical antipsychotic agent.

2012-09-01

[J. Chromatogr. Sci. 50(8) , 727-32, (2012)]

Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.

2012-10-01

[Psychiatry Clin. Neurosci. 66(6) , 534-5, (2012)]

More Articles...